SUBSCRIBE TO OUR RSS
The Burrill Report
April 18, 2011
[Please login to post comments]
Pharma Faces Shrinking Returns
Podcast: December 9, 2013
FDA Warns 23andMe to Stop Selling its DNA Tests
Agency says the DTC genetic testing firm needs its approval to market its kit and service.
Editas Medicine Launches with $43M in Funding
Biotech will use genome editing to develop new class of therapeutics.
Egalet Teams with Shionogi in $425M Deal
Partners will develop abuse-resistant pain pills.
Why Pharma Companies Are Looking More Like Biotechs
Podcast: December 2, 2013
Global Drug Spending to Reach $1 Trillion in 2014
Growth fueled by greater access by expanding middle class, improving economies.
FDA Approves First Next-Gen Sequencer as Diagnostic
Agency believes marketing authorization will speed up clinical use of genetic information.
Clovis Oncology Acquires Ethical Oncology Science for Up to $420M
Gains rights to targeted experimental cancer therapeutic lucitanib.
Royal DSM and JLL Create $2.6B CMO
Dutch food and chemicals company spins off pharma services unit into joint venture.
VCs Launch Two Biotechs Focused on the Gut
Flagship Ventures’ Seres Health will explore the microbiome while Avalon Ventures’ and GSK’s Sitera will tackle celiac disease.
Tweets from @burrillreport/biobuzz
Copyright 2013 Burrill & Company.
FACEBOOK AND TWITTER